Calendar

Nov
3
Wed
Stem Cells & the Immune System: At the Crossroads of Regeneration
Nov 3 @ 11:00 am – 5:00 pm

REGISTERSPEAKERS | LIGHTNING TALKS |SPONSORS | COVID INFO

The IRM is excited to announce that we are partnering with the Institute for Immunology (IFI) for our fall 2021 symposium, Stem Cells & the Immune System: At the Crossroads of Regeneration. This hybrid in-person/virtual event will feature external speakers and Penn scientists discussing a rapidly emerging question: how does the immune system influence regeneration throughout the body?

Recent studies have pointed to a role for the cells of the immune system in modulating stem cell activity in a number of different tissues: T cells infiltrating neurogenic niches; inflammation mediating alveolar regeneration; macrophages providing transient muscle stem cell niches and more. Our fall symposium will explore these and related topics, focusing on the impact on stem cell biology.

Penn/CHOP faculty, postdocs, students, and staff are invited to join us in person in the Smilow Rubenstein Auditorium and Commons.

Speakers

Anne Brunet, Ph.D. (Stanford University) – Mechanisms of stem cell aging

Shruti Naik, Ph.D. (New York University) – Eavesdropping on the conversation between immune cells and epithelia during tissue repair

Joo-Hyeon Lee, Ph.D. (University of Cambridge) – Inflammation shapes lung regeneration

Peter Currie, Ph.D. (Monash University) – The role of a transient macrophage stem cell niche during skeletal muscle repair

Sina Bartfeld, Ph.D. (University of Würzburg) – Infection, innate immune signaling and cancer in the gut – organoids as model   

Kara Spiller, Ph.D. (Drexel University) – Immunomodulatory biomaterials in regenerative medicine

Allie Greenplate, Ph.D. (University of Pennsylvania Immune Health Project) – Immune Health: tracking coordinated systems to direct patient care

Songtao Shi, DDS, Ph.D. (University of Pennsylvania) – TBD

Rumela Chakrabarti, Ph.D. (University of Pennsylvania) – Nurturing role of macrophages in mammary gland development

 

Lightning talks

Students and postdocs: we are looking for lightning talk presenters! Lightning talks are 90 second, 1 slide “pitches” of your work to the gathered audience. If you are conducting research into an area related to our symposium theme, submit an abstract to yaroshc@pennmedicine.upenn.edu by Friday, October 22 at 5 PM. Abstracts must include a title, authors and affiliations, and no more than 250 words describing the research.

COVID-19 Information

In compliance with all University of Pennsylvania and City of Philadelphia guidelines, this symposium is subject to the following COVID-19 procedures:

  • All in-person attendees must be vaccinated against COVID-19. You must attest to your vaccination status on the registration form. Please attend virtually if you are not vaccinated or do not wish to disclose your status.
  • All in-person attendees must wear masks.
  • Email contact information will be collected in case contact tracing is required.
  • No food for drink will be offered at this event.

The IRM will update all registrants if policies and procedures change. Please check this space in advance of the event for the latest information. Current University of Pennsylvania and City of Philadelphia coronavirus are available on the linked websites. If you have any questions, please contact Chris Yarosh, IRM Associate Director (yaroshc@pennmedicine.upenn.edu).

Sponsors

Thank you to our generous sponsors:

Development, a leading primary research journal in the field of developmental biology, will be publishing a special issue, “The Immune System in Development and Regeneration,” in spring 2022. Don’t miss this special collection of research. More information can be found on the journal’s website.
Penn’s Institute for Immunology seeks to advance our knowledge of the basic immunology of inflammation, autoimmunity, cancer, transplantation and infection and to translate this new knowledge to novel strategies for diagnosis, prevention and therapeutic intervention. You can read more about Penn’s home for immunologists on the IFI website.
For more than 30 years, Miltenyi Biotec has played an important role in the design, development, manufacture, and integration of products that empower the advancement of biomedical research and enable cell and gene therapy.
The founders of Lifeline® Cell Technology helped introduce Normal Human Cells Systems and Culture Media for research over 25 years ago. Lifeline® continues to be an industry leader by providing unequaled value through meticulous quality testing, constant innovation, and a passion to provide the best customer and technical care. Lifeline® Cell Technology (Lifeline®) specializes in the development and manufacture of purified primary human cells and optimized reagents for cell culture.